Verona Pharma PLC | Key People and Executives
Jan-Anders Karlsson
Chief Executive Officer & Executive Director
Andrew Sinclair
Non-Executive Director
Rishi Gupta
Non-Executive Director
Mahendra G. Shah
Non-Executive Director
Sven Anders Ullman
Non-Executive Director
Kenneth Thomas Cunningham
Non-Executive Director
David Raymond Ebsworth
Non-Executive Chairman
Jan-Anders Karlsson
Chief Executive Officer & Executive Director
Piers John Morgan
Chief Financial Officer
Andrew Sinclair
Non-Executive Director
Rishi Gupta
Non-Executive Director
Mahendra G. Shah
Non-Executive Director
Sven Anders Ullman
Non-Executive Director
Kenneth Thomas Cunningham
Non-Executive Director
Claire Louise Poll
Legal Counsel
Desiree Luthman
Vice President-Regulatory Affairs
David Raymond Ebsworth
Non-Executive Chairman
| Address |
3 More London Riverside
London Greater London SE1 2RE
United Kingdom
|
|
Employees
|
- |
| Website |
http://veronapharma.com |
| Updated |
07/08/2019 |
| Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases. Verona Pharma's product include, RPL554, is a dual inhibitor of the enzymes phosphodiesterase 3 and 4 that acts as both a bronchodilator and an anti-inflammatory agent in a single compound. Verona Pharma is developing RPL554 for the treatment of chronic obstructive pulmonary disease (COPD), cystic fibrosis, and potentially asthma. |
